Mike Allan Mortensen

University of Southern Denmark, Odense University Hospital, Roskilde Sygehus

Papers

Total Citations

H-Index

About

Mike Allan Mortensen is a Danish urologic surgeon and researcher whose work centers on improving outcomes for prostate cancer patients through advanced imaging, surgical innovation, and surgical education. His most cited study, a 2018 prospective trial on dual-time 18F-FDG-PET/CT in high-risk prostate cancer, demonstrated the potential of delayed imaging to enhance preoperative staging—a proof-of-concept that has influenced nuclear medicine protocols. Mortensen also led the introduction of salvage robot-assisted radical prostatectomy in Denmark, a landmark 2022 pilot study that established a curative option for patients with post-radiation recurrence, filling a critical national treatment gap. His recent 2024 work challenges assumptions in surgical assessment, showing that medical students cannot reliably evaluate robotic surgeons performing radical prostatectomy, thereby refining how surgical performance is measured. With a growing citation footprint and a focus on translating technical advances into clinical practice, Mortensen’s contributions span from the operating room to the classroom, making him a key figure in the evolution of prostate cancer care and surgical training.